Why BGPT?
logo

Review Papers Claim by Claim

Check each claim against its experiments, reported results, scope, and stated limitations.Know what the science actually supports before you trust the answer.

Press Enter ↡ to start review



    Explore by Goal












     Quick Explanation


    Best mechanistic takeaway
    The paper provides cryo-EM structures plus mutagenesis/function to argue that oxoglutarate (two molecules) activates GPR99/OXGR1 via a canonical orthosteric transmembrane pocket, while LTE4 activates from a distinct, non-canonical site above ICL2 (poor TM density prevents direct LTE4 pose certainty), yielding Gq-dominant signaling for oxoglutarate and Gq + weaker Gi engagement for LTE4.
    Evidence anchored in the authors’ structures, densities, and ligand-site mutational/pertussis-toxin/NanoBiT functional logic.



     Long Explanation


    Molecular insights into ligand recognition and signaling of OXGR1 β€” Skeptical, evidence-based paper review
    Focus: how oxoglutarate and LTE4 are recognized and how that maps to G protein signaling bias.
    Anchor:
    Paper metadata (from provided text)
    • Journal/DOI: Nature Communications, 10.1038/s41467-025-67101-z
    • Resolution (oxoglutarate complex): 3.16 Γ…
    • Resolution (LTE4 complex): 2.84 Γ…
    • PDB/EMDB deposits: PDB 8YYW / 8YYX; EMDB EMD-39681 / EMD-39682
    • Core functional readouts: IP1 (Gq), cAMP (Gi), NanoBiT basal G-protein dissociation
    Cryo-EM data scale & map resolution
    Values are taken directly from the paper’s cryo-EM refinement summary (final particle counts and global resolutions).
    Mechanistic mapping: ligand β†’ site β†’ signaling outputs
    The LTE4 orthosteric-pocket density is reported as insufficient/confounded, so the LTE4 site is inferred from alternative-site modeling plus mutagenesis and signaling tests.
    Mutagenesis logic: which residues matter for which ligand?
    This visualization encodes the paper’s qualitative directionality described in the provided text: OG1 mutations strongly reduce oxoglutarate-driven IP1; OG2 mutations shift potency (EC50) without reducing Emax; LTE4-site mutations markedly reduce LTE4-driven IP1 with little effect on oxoglutarate signaling.
    What the paper does well (high-confidence claims)
    • Two-site oxoglutarate engagement is directly supported by cryo-EM densities (two distinct ligand densities in the orthosteric pocket) and then cross-validated by targeted alanine substitutions and Gq/IP1 functional readouts.
    • Signaling bias mapping is experimentally separated by pathway readouts: oxoglutarate is tested against cAMP (Gi) and fails to drive it, whereas LTE4 is tested and shows pertussis-toxin sensitive cAMP inhibition consistent with Gi participation.
    • Basal activity is directly tested (NanoBiT G protein dissociation assay) to argue against constitutive signaling in their system.
    Where the evidence is weaker / uncertain (explicit skeptical notes)
    • LTE4 pose is not directly resolved with strong TM-pocket EM density.
      • The authors explicitly report that they did not find confident extra density for LTE4 in the orthosteric pocket and that the alternative LTE4-site density is less well defined.
      • This means the alternative-site assignment is primarily supported by combination inference (model fit + docking/MD stability + mutational functional block).
    • Overexpression + engineered complexes can bias receptor conformational selection.
      • They form GPR99/OXGR1–Gq complexes via co-expression in Sf9 and use a chimeric/engineered GΞ±q design to stabilize the complex for cryo-EM.
      • Functional assays are performed in human cell lines (HeLa/HEK293T) but still in heterologous expression contexts.
      • That’s not β€œwrong,” but it is a known limitation: signaling linkage and ligand residence can differ in native tissues.
    • Computational energetics/dynamics add plausibility but are not absolute proof.
      • Docking and MD support stability/preference for the alternative binding mode, but energetic ranking and force-field accuracy remain uncertainty sources.
    What would disprove / change the conclusions?
    • LTE4-binding-site refutation: if LTE4 remains functional (IP1 and/or cAMP effects) after mutating the proposed alternative-site residues (C141, R148, C149) or if unambiguous cryo-EM density places LTE4 in the orthosteric pocket rather than above ICL2.
    • Oxoglutarate-site refutation: if OG1/OG2-contact alanine mutations do not produce the reported potency/efficacy separations (OG1 reducing potency+efficacy, OG2 shifting EC50 without Emax loss), or if two-site binding is not observed under alternative cryo-EM conditions.
    This will iteratively verify and stress-test the ligand-site/signaling conclusions using the deposited structure information described in the paper.


    Feedback:    

    Updated: March 23, 2026

     BGPT Paper Review


    Study Novelty

    90%

    Direct cryo-EM structures plus functional mutagenesis connect two chemically distinct ligands (oxoglutarate and LTE4) to distinct binding modes and signaling outputs for the specific receptor GPR99/OXGR1, with an inferred non-canonical LTE4 site when TM density is insufficient. The two-site oxoglutarate activation model is a mechanistic advance for a low-affinity dicarboxylate receptor context.


    Scientific Quality

    90%

    High-quality structure determination and multi-layer validation (cryo-EM densities, targeted alanine mutagenesis with differential potency/efficacy effects, and orthogonal signaling assays with PTX and NanoBiT). Main quality caveat: the LTE4 binding pose is not confidently resolved in the TM pocket density, so the alternative-site assignment is inference-supported rather than fully density-anchored.


    Study Generality

    80%

    Mechanistically generalizable to GPCR ligand recognition logic: how small charged dicarboxylates can use multi-site engagement for activation while bulky lipid mediators can engage from non-canonical sites to bias signaling. But conclusions are receptor-specific and require follow-up for broader GPCR family generalization.


    Study Usefulness

    90%

    Very useful for structural/functional hypothesis generation: specific residue lists, deposited structures/maps, and an explicit ligand-site/signaling framework that can guide targeted experiments (including strategies to test LTE4 pose).


    Study Reproducibility

    90%

    Methods are detailed (expression systems, cryo-EM processing tools, model building/refinement/validation, assay workflows) and key results are supported by openly deposited structures and EM maps. Remaining reproducibility risk is the inference-heavy LTE4 pose.


    Explanatory Depth

    90%

    Deep mechanistic narrative: two oxoglutarate molecules in primary/accessory sites explain activation thresholds; detailed motif/micro-switch coupling to Gq and parallel motif rearrangements for LTE4 activation are proposed. Depth is constrained only by LTE4 pose ambiguity in density.


    🎁 Authors: Collect 500 Free Science Tokens (β‰ˆ $50.0 USD)

    Claim My Author Tokens

    Use for 125 days of free BGPT access (4 tokens = 1 day) or trade/sell (β‰ˆ $50.0 USD)

     Top Data Sources ExportMCP


     Analysis Wizard



    It builds a residue–ligand–pathway interaction table from the paper’s described OG1/OG2/LTE4 residues, then visualizes a confidence-coded network for density-supported vs inference-supported links using the provided residue lists.



     Hypothesis Graveyard


    The LTE4 model would be false if orthosteric-pocket EM densities unambiguously show LTE4 in the TM pocket and LTE4-site mutations (C141/R148/C149) fail to reduce LTE4 signaling, indicating the alternative site assignment is an artifact of modeling.


    If oxoglutarate’s two-density assignment is an imaging/processing artifact, then two-site residues (OG1/OG2 contacts) would not yield the distinct functional pattern (OG1 affecting efficacy+potency vs OG2 shifting EC50 only).

     Science Art


    Paper Review: Molecular insights into ligand recognition and signaling of OXGR1. Science Art

     Science Movie


    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT






     Trending